ScreenerHero

AZN AstraZeneca PLC

STO · SE · Healthcare · Drug Manufacturers - General · astrazeneca.com
1560.00SEK-0.89%Mkt Cap: 231.42B $P/E: 24.90

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza,…

Industry Peers

Drug Manufacturers - General
Screen all
LLY
Eli Lilly and Company
$1.02TUSDP/E 38.4
JNJ
Johnson & Johnson
$609.54BUSDP/E 29.3
ABBV
AbbVie Inc.
$469.63BUSDP/E 75.1
RO
Roche Holding AG
$325.55BUSDP/E 23.4
MRK
Merck & Co., Inc.
$344.27BUSDP/E 110.7
NVS
Novartis AG
$267.87BUSDP/E 21.3
NOVN
Novartis AG
$252.68BUSDP/E 22.2
AMGN
Amgen Inc.
$217.86BUSDP/E 25.0
GILD
Gilead Sciences, Inc.
$179.33BUSD
NVO
Novo Nordisk A/S
$165.76BUSDP/E 9.2
PFE
Pfizer Inc.
$156.23BUSDP/E 36.1
BMY
Bristol-Myers Squibb Company
$120.13BUSDP/E 13.0
SNY
Sanofi
$94.67BUSDP/E 20.8
SAN
Sanofi
$91.14BUSDP/E 21.5
GSK
GSK plc
$93.26BUSDP/E 14.7
GSK
GSK plc
$76.61BUSDP/E 14.9
BAYN
Bayer Aktiengesellschaft
$46.94BUSD
BIIB
Biogen Inc.
$33.04BUSDP/E 39.7
MRV
Marvell Technology, Inc.
$28.71BUSDP/E 89.5
ORNBV
Orion Oyj
$12.34BUSDP/E 19.4

Key Statistics

Company
Market Cap231.42B USD
Enterprise Value236.14B USD
Revenue (TTM)5.87B USD
Gross Profit4.60B USD
Net Income (TTM)978.04M USD
Revenue/Share39.59 SEK
Last Price1560.00 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees96.1K
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINGB0009895292
Valuation
P/E (Trailing)24.90
P/E (Forward)15.58
PEG1.10
EV/EBITDA124.03
EV/Revenue40.23
P/S39.78
P/B48.54
EPS (TTM)62.65
EPS (Forward)101.02
52W Range
1385.0032% of range1925.50
52W High1925.50 SEK
52W Low1385.00 SEK
Profitability
Gross Margin81.90%
Oper. Margin23.46%
EBITDA Margin32.44%
Profit Margin17.41%
ROE21.01%
ROA8.96%
Growth
Revenue Growth6.40%
Earnings Growth2.50%
Cash Flow & Leverage
Operating CF1.39B USD
CapEx (TTM)564.83M USD
FCF Margin7.99%
FCF Yield0.20%
Net Debt2.62B USD
Net Debt/EBITDA1.38
Balance Sheet
Debt/Equity0.60
Current Ratio0.89
Quick Ratio0.66
Book Value/Sh32.43 SEK
Cash/Share3.20 SEK
Dividends
Fwd Div Rate30.24 SEK
Trail. Div Rate3.23 SEK
Div. Yield1.92%
5Y Avg Yield2.02%
Payout Ratio46.95%
Ex-Div DateAug 6, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2016.14 SEK
Upside (mean)+29.2%
Target Range1797.47 SEK – 2177.31 SEK
1797.47+29.2% to mean2177.31
# Analysts3
Ownership
Shares Out.1.55B
Float1.54B
Insiders0.05%
Institutions65.02%
Technical
SMA 501578.63 (-1.2%)
SMA 2001710.44 (-8.8%)
Beta0.20
S&P 52W Chg14.58%
Avg Vol (30d)507.71K
Avg Vol (10d)428.36K
Technical Indicators
RSI (14)40.9
MACD5.2465
MACD Signal12.1508
MACD Hist.-6.9043
BB Upper1691.94 SEK
BB Middle1603.47 SEK
BB Lower1515.01 SEK
BB Width11.03%
ATR (14)36.63 SEK
Vol Ratio (20d)0.66x